Literature DB >> 30013191

Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis.

Jin Woo Park1, Yun-Cheol Chae1, Ji-Young Kim1, Hyein Oh1, Sang-Beom Seo2.   

Abstract

The histone methyltransferase multiple myeloma SET domain protein (MMSET/WHSC1) is highly expressed in diverse tumor types, and its expression appears to be involved in cell proliferation. In this study, we report that MMSET interacts with and methylates Aurora kinase A (AURKA). We show that MMSET-mediated methylation of AURKA induces interaction with p53 as well as enhanced kinase activity of AURKA, which results in the proteasomal degradation of p53. MMSET-mediated p53 degradation increases cell proliferation and results in oncogenic activity. Furthermore, knockdown of MMSET potently inhibits tumorigenic cells and renders them sensitive to growth inhibition by the therapeutic drug, alisertib (AURKA inhibitor). Taken together, our results suggest that MMSET is a regulator of p53 stability via methylation of AURKA in proliferating cells and might be a potential therapeutic target in solid tumors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30013191     DOI: 10.1038/s41388-018-0393-y

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

Review 1.  The MDM2-p53 interaction.

Authors:  Ute M Moll; Oleksi Petrenko
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

2.  In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.

Authors:  Masayo Morishita; Damiaan Mevius; Eric di Luccio
Journal:  BMC Struct Biol       Date:  2014-12-12
  2 in total
  11 in total

1.  Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.

Authors:  Xiaoxiao Huang; Richard D LeDuc; Luca Fornelli; Alissa J Schunter; Richard L Bennett; Neil L Kelleher; Jonathan D Licht
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

2.  NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein.

Authors:  Da Song; Jingqin Lan; Yaqi Chen; Anyi Liu; Qi Wu; Chongchong Zhao; Yongdong Feng; Jing Wang; Xuelai Luo; Zhixin Cao; Xiaonian Cao; Junbo Hu; Guihua Wang
Journal:  Oncogene       Date:  2021-03-19       Impact factor: 9.867

3.  Wolf-Hirschhorn Syndrome-Associated Genes Are Enriched in Motile Neural Crest Cells and Affect Craniofacial Development in Xenopus laevis.

Authors:  Alexandra Mills; Elizabeth Bearce; Rachael Cella; Seung Woo Kim; Megan Selig; Sangmook Lee; Laura Anne Lowery
Journal:  Front Physiol       Date:  2019-04-12       Impact factor: 4.566

4.  Protein phosphatase 2 regulatory subunit B''Alpha silencing inhibits tumor cell proliferation in liver cancer.

Authors:  Huijuan Chen; Jing Xu; Peixiao Wang; Qingming Shu; Lihong Huang; Jing Guo; Xuyi Zhang; Hongying Zhang; Ying Wang; Zhongyang Shen; Xinguo Chen; Qing Zhang
Journal:  Cancer Med       Date:  2019-10-24       Impact factor: 4.452

5.  The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.

Authors:  Hiroshi Tanaka; Tomoka Igata; Kan Etoh; Tomoaki Koga; Shin-Ichiro Takebayashi; Mitsuyoshi Nakao
Journal:  Aging Cell       Date:  2020-06-22       Impact factor: 9.304

6.  Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.

Authors:  Jing Liu; Ying Xie; Jing Guo; Xin Li; Jingjing Wang; Hongmei Jiang; Ziyi Peng; Jingya Wang; Sheng Wang; Qian Li; Linquan Ye; Yuping Zhong; Qiguo Zhang; Xiaozhi Liu; David M Lonard; Jin Wang; Bert W O'Malley; Zhiqiang Liu
Journal:  Nat Commun       Date:  2021-02-15       Impact factor: 14.919

Review 7.  Genome Instability in Multiple Myeloma: Facts and Factors.

Authors:  Anna Y Aksenova; Anna S Zhuk; Artem G Lada; Irina V Zotova; Elena I Stepchenkova; Ivan I Kostroma; Sergey V Gritsaev; Youri I Pavlov
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

8.  Effects of Aurora kinase A on mouse decidualization via Stat3-plk1-cdk1 pathway.

Authors:  Peng-Chao Wang; Si-Ting Chen; Zeng-Ming Yang
Journal:  Reprod Biol Endocrinol       Date:  2021-10-29       Impact factor: 5.211

9.  Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer: In silico Screening of Therapeutic Compounds and in vitro Characterization.

Authors:  Saisai Tian; Lu Fu; Jinbo Zhang; Jia Xu; Li Yuan; Jiangjiang Qin; Weidong Zhang
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

10.  Posttranslational modification of Aurora A-NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma.

Authors:  Hongmei Jiang; Yixuan Wang; Jingjing Wang; Yafei Wang; Sheng Wang; Enyang He; Jing Guo; Ying Xie; Jingya Wang; Xin Li; Ziyi Peng; Mengqi Wang; Jian Hou; Zhiqiang Liu
Journal:  Clin Transl Med       Date:  2022-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.